Ceres Nanosciences
NIH Awards Ceres Nanosciences $8.2M for Wastewater-Based COVID-19 Surveillance
The Manassas, Virginia-based firm will collaborate with researchers at Emory University to develop a system for the Atlanta metro area.
Ceres plans to develop its Nanotrap technology to isolate undetectable levels of circulating tumor DNA in blood samples from non-small cell lung cancer patients.
Ceres Nanosciences Nabs $243K SBIR Grant to Adapt RNA Capture Tech for Portable Sequencing
The firm's Nanotrap virus particles provide an alternative to RNA extraction kits and could help improve detection for respiratory viruses, including SARS-CoV-2.
NIH Awards $129M to Nine Dx Firms for Rapid COVID-19 Diagnostics
Some of the firms will receive money to speed up test development, while others will use the funds to expand their testing and manufacturing capacity.